Treatment of postherpetic neuralgia by bone marrow aspirate injection: A case report

doi:10.12998/wjcc.v11.i15.3619

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1826)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

124

WORD

HTML

1127

Tables (1-2)

250

Sum=1522

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

117

Download

187

Sum=304

May 26, 2023 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. May 26, 2023; 11(15): 3619-3624
Published online May 26, 2023. doi: 10.12998/wjcc.v11.i15.3619

Treatment of postherpetic neuralgia by bone marrow aspirate injection: A case report

Takahiro Honda Pazili

Takahiro Honda Pazili, Regenerative Medicine, Department of Cell Therapy, Japan Tokyo Stem Cell Transplant Research Institute, Tokyo 104-0061, Japan

Author contributions: Honda Pazili T did all the work for this paper.

Informed consent statement: Informed written consent for the publication of this report and any accompanying images was obtained from the patient.

Conflict-of-interest statement: The author declares that he has no conflict of interest to disclose.

CARE Checklist (2016) statement: The author has read the CARE Checklist (2016), and the manuscript was prepared and revised according to it.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Takahiro Honda Pazili, MD, Doctor, Regenerative Medicine, Department of Cell Therapy, Japan Tokyo Stem Cell Transplant Research Institute, Chuuouku Ginza 4-3-9-8F, Tokyo 104-0061, Japan. hatakahiro90@gmail.com

Received: January 29, 2023
Peer-review started: January 29, 2023
First decision: February 28, 2023
Revised: March 27, 2023
Accepted: April 17, 2023
Article in press: April 17, 2023
Published online: May 26, 2023

Core Tip

Core Tip: To our knowledge, this is the first report of bone marrow aspirate concentrates (BMAC) curing post-herpetic neuralgia (PHN). BMAC contains bone marrow mesenchymal stem cells and other important cytokines and has favorable results in treating joint pain. PHN is difficult to cure, and conventional medicines do not work well in most cases. BMAC may serve as a radical treatment. The fact that BMAC was useful for the treatment of PHN indicates that BMAC can be applied for other pain-related conditions.